Evidence map›Paper›PMID 39108195›Full record

ArticleMolecular genetics & genomic medicine2024

Maculopathy and adult-onset ataxia in patients with biallelic MFSD8 variants.

Sigurd Dobloug, Ulrika Kjellström, Glenn Anderson, Emily Gardner, Sara E Mole, Jayesh Sheth, Andreas Puschmann

Abstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sigurd DoblougDepartment of Neurology, Helsingborg General Hospital, Helsingborg, Sweden.
Ulrika KjellströmLund University, Skåne University Hospital, Ophthalmology, Lund, Sweden.ORCID https://orcid.org/0000-0002-7316-4976
Glenn AndersonDepartment of Histopathology, Great Ormond Street Hospital, London, UK.
Emily GardnerGreat Ormond Street Institute of Child Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-1265-2298
Sara E MoleGreat Ormond Street Institute of Child Health, University College London, London, UK.ORCID https://orcid.org/0000-0003-4385-4957
Jayesh ShethFoundation for Research in Genetics and Endocrinology, Institute of Human Genetics, Ahmedabad, India.
Andreas PuschmannLund University, Skåne University Hospital, Neurology, Lund, Sweden.ORCID https://orcid.org/0000-0002-3201-8198

Funding

Avtal för läkarutbildning och forskning (ALF)BioMarin PharmaceuticalHans-Gabriel och Alice Trolle-Wachtmeisters stiftelse för medicinsk forskningIntramural research fund of FRIGE-Institute of Human GeneticsNational Institute for Health Research Biomedical Research Centre at University College London Great Ormond Street Institute of Child HealthÖgonfondenRegion SkåneSkånes universitetssjukhusStiftelsen för Synskadade i f.d. Malmöhus länStiftelsen Kronprinsessan Margaretas Arbetsnämnd för SynskadadeStiftelsen Synfrämjandets ForskningsfondStig och Ragna Gorthons Stiftelse
6 · The paper itself

Abstract

backgroundBiallelic variants in the major facilitator superfamily domain containing 8 gene (MFSD8) are associated with distinct clinical presentations that range from typical late-infantile neuronal ceroid lipofuscinosis type 7 (CLN7 disease) to isolated adult-onset retinal dystrophy. Classic late-infantile CLN7 disease is a severe, rare neurological disorder with an age of onset typically between 2 and 6 years, presenting with seizures and/or cognitive regression. Its clinical course is progressive, leading to premature death, and often includes visual loss due to severe retinal dystrophy. In rare cases, pathogenic variants in MFSD8 can be associated with isolated non-syndromic macular dystrophy with variable age at onset, in which the disease process predominantly or exclusively affects the cones of the macula and where there are no neurological or neuropsychiatric manifestations.

methodsHere we present longitudinal studies on four adult-onset patients who were biallelic for four MFSD8 variants.

resultsTwo unrelated patients who presented with adult-onset ataxia and had macular dystrophy on examination were homozygous for a novel variant in MFSD8 NM_152778.4: c.935T>C p.(Ile312Thr). Two other patients presented in adulthood with visual symptoms, and one of these developed mild to moderate cerebellar ataxia years after the onset of visual symptoms.

conclusionsOur observations expand the knowledge on biallelic pathogenic MFSD8 variants and confirm that these are associated with a spectrum of more heterogeneous clinical phenotypes. In MFSD8-related disease, adult-onset recessive ataxia can be the presenting manifestation or may occur in combination with retinal dystrophy.

Indexed as

Macular DegenerationAdultAge of OnsetAllelesAtaxiaFemaleHumansMaleMembrane Transport ProteinsMiddle AgedMutationPhenotypeMembrane Transport ProteinsMFSD8 protein, humanataxiaCLN7MFSD8NCL7neuronal ceroid lipofuscinosisretinal degeneration

Identifiers

PMID39108195
PMCPMC11303817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.